Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00573079 · ClinicalTrials.gov registry record
Acute Kidney Injury in Premature Infants
A clinical trial of Acute Kidney Injury, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 237
- Enrollment target
- 1
- Study location
NCT00573079 is a study of Acute Kidney Injury that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 237 participants, below the 2,328-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00573079, a study of Acute Kidney Injury, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 237 participants
- Enrollment target
- 1
- Study location
Study Summary
Our first Aim is to describe how common a sudden decrease in renal function happens in premature infants in a neonatal intensive care unit. We also want to see how a sudden loss of renal function affects survival. Finally, we will explore non-invasive markers to identify a sudden decrease in renal function from urinary samples.
Conditions Studied
Study Locations (1)
Alabama
- UAB - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 237 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00573079
The ClinicalTrials.gov registry entry for NCT00573079 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 237 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,328-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (90% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Kidney Injury appearing as the primary indexed condition, and to 0 interventions.
NCT00573079 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT00573079 about?
NCT00573079 is a clinical study titled "Acute Kidney Injury in Premature Infants". Our first Aim is to describe how common a sudden decrease in renal function happens in premature infants in a neonatal intensive care unit. We also want to see how a sudden loss of renal function affects survival. Finally, we will explore non-invasive markers to identify a sudden decrease in renal f...
What is the current status of trial NCT00573079?
This trial is currently completed. The enrollment target is 237 participants. The study started on 2007-12. Estimated completion is 2010-12-31.
What conditions does trial NCT00573079 study?
This clinical trial studies the following conditions: Acute Kidney Injury.
Who is sponsoring clinical trial NCT00573079?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00573079 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ultra-Low Contrast Angiography in AKI
RECRUITING · Phase 3
-
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
RECRUITING
-
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
RECRUITING
-
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
RECRUITING · Phase 2
-
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
RECRUITING · Phase 1
-
Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.